Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
0 minute read
  • Biotech
  • General
  • News

Tivic Health Highlights Study With Feinstein Institutes for Medical Research at Northwell Health Of Non-Invasive Cervical Vagus Nerve Stimulation, Demonstrating That Personalizing The Stimulation Parameters To Each User Enhanced Autonomic Effects

By Benzinga Newsdesk
Today, 4:31 PM

TIVC

Read More
0 minute read
  • Biotech
  • General
  • News

Tivic Health Highlights Study With Feinstein Institutes for Medical Research at Northwell Health Of Non-Invasive Cervical Vagus Nerve Stimulation, Demonstrating That Personalizing The Stimulation Parameters To Each User Enhanced Autonomic Effects

By Benzinga Newsdesk
Today, 4:31 PM

TIVC

Read More
1 minute read
  • Biotech
  • Economics
  • General
  • Macro Economic Events
  • News

‘Military To Start Testing Service Members For The Psychedelic Psilocin, Memo Shows’ – Marijuana Moment

By Benzinga Newsdesk
Today, 4:31 PM
https://www.marijuanamoment.net/military-to-start-testing-service-members-for-the-psychedelic-psilocin-memo-shows/

ATAI

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • News

Altamira Therapeutics’ SemaPhore Delivery Platform Shows Significant Synergis-tic Effects Of ZBTB46 mRNA With PD1 Immunotherapy In Control Of Tumor Growth In Animal Model

By Happy Mohamed
Today, 4:31 PM
Preprint of results from animal study shows restriction of tumor growth in mice treated with ZBTB46 mRNA nanoparticles based on Altamira's SemaPhore™ delivery technology Nanoparticle treatment combined with

CYTO

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News

Despite Failed Phase 3 Study, FDA Staff Says Biogen’s ALS Drug May Have Clinical Benefit

By Vandana Singh
Today, 4:31 PM
FDA’s Peripheral and Central Nervous System Drugs Advisory Committee will virtually meet on Wednesday, March 22, to discuss Biogen Inc’s (NASDAQ:BIIB) ALS…

BIIB

Read More
1 minute read
  • After-Hours Center
  • Biotech
  • General
  • Movers
  • News
  • Penny Stocks

Why Enzo Biochem Stock Is Skyrocketing After Hours

By Adam Eckert
Today, 4:31 PM
Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America</

ENZ

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News

Roivant Sciences Highlights Topline Data From Atopic Dermatitis Drug In Patients As Young As 2 Years

By Vandana Singh
Today, 4:31 PM
Dermavant Sciences, a Roivant Sciences Ltd. (NASDAQ:ROIV) company, announced results from ADORING 2 Phase 3 study evaluating VTAMA (tapinarof) cream, 1% in…

ROIV

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Small Cap

Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study

By Vandana Singh
Today, 4:31 PM
Protagonist Therapeutics Inc (NASDAQ:PTGX) announced topline results from the blinded, placebo-controlled, randomized withdrawal portion of REVIVE of rusfertide for polycythemia vera,…

JNJ

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks

Why Jounce Therapeutics Stock Is Moving Higher Today?

By Vandana Singh
Today, 4:31 PM
The Board of Directors of Jounce Therapeutics Inc (NASDAQ:JNCE) confirmed that Concentra Biosciences LLC made an unsolicited and non-binding proposal to acquire 100%…

JNCE

Read More
5 minute read
  • Biotech
  • Cryptocurrency
  • General
  • Global
  • Health Care
  • Large Cap
  • Markets
  • Media
  • News
  • Penny Stocks
  • Tech
  • Top Stories

Apple Eases On Bonus & Hiring, Federal Reserve Mulls Tougher Rules After SVB Failure, Meta-Backed Undersea Cable Project Delayed By China: Today’s Top Stories

By Vandana Singh
Today, 4:31 PM
Reuters Fed Mulling Tougher Rules For Midsize Banks After SVB Crash

AAPL

Posts navigation

1 2 … 789 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service